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Involuntary choreiform movements are a clinical hallmark of Huntington’s disease. Studies in clinically affected patients suggest
a shift of motor activations to parietal cortices in response to progressive neurodegeneration. Here, we studied pre-symptomatic
gene carriers to examine the compensatory mechanisms that underlie the phenomenon of retained motor function in the
presence of degenerative change. Fifteen pre-symptomatic gene carriers and 12 matched controls performed button presses
paced by a metronome at either 0.5 or 2 Hz with four fingers of the right hand whilst being scanned with functional magnetic
resonance imaging. Subjects pressed buttons either in the order of a previously learnt 10-item finger sequence, from left to right,
or kept still. Error rates ranged from 2% to 7% in the pre-symptomatic gene carriers and from 0.5% to 4% in controls,
depending on the condition. No significant difference in task performance was found between groups for any of the conditions.
Activations in the supplementary motor area (SMA) and superior parietal lobe differed with gene status. Compared with healthy
controls, gene carriers showed greater activations of left caudal SMA with all movement conditions. Activations correlated with
increasing speed of movement were greater the closer the gene carriers were to estimated clinical diagnosis, defined by the
onset of unequivocal motor signs. Activations associated with increased movement complexity (i.e. with the pre-learnt 10-item
sequence) decreased in the rostral SMA with nearing diagnostic onset. The left superior parietal lobe showed reduced activation
with increased movement complexity in gene carriers compared with controls, and in the right superior parietal lobe showed
greater activations with all but the most demanding movements. We identified a complex pattern of motor compensation in
pre-symptomatic gene carriers. The results show that preclinical compensation goes beyond a simple shift of activity from
premotor to parietal regions involving multiple compensatory mechanisms in executive and cognitive motor areas. Critically, the
pattern of motor compensation is flexible depending on the actual task demands on motor control.
Keywords: pre-symptomatic Huntington’s disease; fMRI; motor control
Abbreviations: fMRI = functional MRI; M1 = primary sensorimotor cortex; PET = positron emission tomography; PMd = dorsal
premotor cortex; ROIs = regions of interests; rTMS = repetitive transcranial magnetic stimulation; SMA = supplementary motor area;
SPL = superior parietal lobe; UHDRS = Unified Huntington’s Disease Rating Scale
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Introduction
Huntington’s disease is an autosomal dominant inherited neurode-
generative disorder caused by an expansion of CAG repeats in the
gene encoding huntingtin (Huntington’s Disease Collaborative
Research Group, 1993). Affected patients show progressive
motor and cognitive dysfunction with psychiatric problems (for a
recent review see Walker, 2007). Generalized chorea, the clinical
hallmark of Huntington’s disease has been the focus of a number
of functional neuroimaging studies (Bartenstein et al., 1997;
Weeks et al., 1997; Gavazzi et al., 2007). A first study used
positron emission tomography (PET) to examine changes in
regional cerebral blood flow when mild or moderately affected
patients performed auditory paced unilateral finger opposition
movements (Bartenstein et al., 1997). In that study,
Huntington’s disease patients showed reduced task related activa-
tion in the striatum, rostral supplementary motor area (pre-SMA)
and contralateral primary sensorimotor cortex (M1) compared
with healthy controls, while parietal and posterior cingulate areas
were relatively overactive (Bartenstein et al., 1997). The authors
suggested a shift of cortical motor control towards more posterior
and parietal brain regions to counterbalance dysfunctional
pre- and primary motor areas.
Conflicting results come from a more recent functional MRI
(fMRI) study, which examined clinically affected Huntington’s
disease patients while performing a finger tapping task (Gavazzi
et al., 2007). Although the authors found reduced activation in
M1 during tapping, there was a concurrent increase in activation
in caudal supplementary motor area (SMA), which seems to
contradict a shift of activation away from pre-motor areas. More
divergent data are to be found in another PET study in which
Huntington’s disease patients with chorea and bradykinesia
performed freely chosen joystick movements (Weeks et al.,
1997). Here, reduced activation in pre-motor areas was combined
with a reduction of activity in parietal areas. A straightforward
interpretation of these apparently conflicting results in affected
Huntington’s disease patients is precluded either because of
between-group differences in performance, or because perfor-
mance during functional imaging was not recorded.
The availability of a sensitive and specific genetic test for
Huntington’s disease allows preclinical diagnosis, many years
before the onset of unequivocal motor signs. Years to clinical
onset can be estimated based on age and number of CAG repeats
(Langbehn et al., 2004). Morphometric MRI studies in these
pre-symptomatic mutation carriers show degeneration, primarily
affecting the striatum but also including cortical areas (Thieben
et al., 2002; Rosas et al., 2005, 2006). Despite those structural
changes, behavioural studies in pre-symptomatic mutation carriers
have demonstrated abnormalities only on more demanding motor
tasks (see Farrow et al., 2006 for an overview). This may be
attributed to an effective recruitment of compensatory mecha-
nisms that help to maintain routine motor functions in the context
of slowly progressive neurodegeneration. Indeed, functional
imaging studies of working memory (Wolf et al., 2007) or
motor sequence learning (Feigin et al., 2006) suggest a com-
pensatory reorganisation in the cortex. A deeper understanding
of such compensatory processes could prove critical for the
understanding of early and pre-symptomatic stages of degenera-
tion in Huntington’s disease, which may also have relevance for
other basal ganglia disorders.
While the PET study by Feigin and colleagues (2006) studied
neuronal activations in pre-symptomatic mutation carriers during
trial and error learning of a motor sequence based on feedback,
we chose an experimental motor set up that taps into executive
(speed of movement) and cognitive (movement complexity)
aspects of motor control (Lehericy et al., 2006). Based on previous
work in affected Huntington’s disease patients with a similar task
(Bartenstein et al., 1997), we hypothesized that distinct parietal
areas will show compensatory increases in activation to keep
motor performance within the normal range. In the light of the
apparently conflicting fMRI results on motor compensation in
clinically affected Huntington’s disease patients, we predicted
that the regional expression of compensatory activity in premotor
and parietal areas will critically depend on task difficulty and on
which aspects of motor control are probed by the experimental
motor task.
Material and Methods
Participants
We examined a group of 15 pre-symptomatic gene carriers (7 F, 8 M;
mean age: 36.9 years; range: 26–49) and a group of 12 age- and
sex-matched controls (4 F, 8 M; mean age: 36.5 years; range:
23–60). All participants were right-handed. A neurologist experienced
in Huntington’s disease assessed subjects with the Unified
Huntington’s Disease Rating Scale (UHDRS) to confirm pre-
symptomatic status (i.e. no unequivocal Huntington’s disease motor
signs) prior to inclusion. Pre-symptomatic gene carriers were selected
to cover a wide range of years to estimated onset based on age
and the number of CAG repeats (Langbehn et al., 2004) to allow
meaningful correlations. Refer Table 1 for full demographic and clinical
details. The local Ethics Committee approved the study and all parti-
cipants gave written informed consent according to the declaration of
Helsinki.
Experimental procedure
Following up on previous work in Huntington’s disease (Bartenstein
et al., 1997), subjects performed auditory paced sequential finger
Table 1 Demographic details reported with median and
range
Controls Pre-symptomatic
Huntington’s disease
Number of subjects 12 15
Female/Male 4/8 7/8
Age 32.5 (23:60) 37 (26:54)
Number CAG repeats NA 42 (39:47)
Motor score NA 2 (0:17)
Year to 60%
probability of
diagnostic onset
NA 12.51 (6.3:35.4)
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movements with the second to fifth fingers of their right dominant
hand during fMRI. An MRI-compatible hand mould was crafted
in-house, allowing participants to comfortably press all four buttons
while simultaneously restricting excessive movement. The tips of the
four fingers are placed beside each other on top of four buttons while
the thumb rests beside them. The experimental paradigm varied the
executive (speed) and cognitive (complexity) demands of the task.
Participants performed sequential finger movements at a rate of
0.5 or 2 Hz (referred to as ‘slow’ and ‘fast’ sequences). Each move-
ment was paced by a metronome click presented via headphones.
Participants performed two types of sequence. The first was regular
and consisted of unidirectional sequential button presses with the
index, middle, ring and little fingers (i.e. 1–2–3–4–1–2–3–4 referred
to as the ‘simple’ sequence). The other sequence was irregular but
without immediate repetitions (e.g. 1–3–4–2–3–4–2–1–3–4; referred
to as the ‘complex’ sequence). A new complex sequence was gener-
ated for each participant. The simple sequence remained unchanged as
performing it in reverse order is of itself less natural and more difficult.
Participants were trained on the simple and complex sequence in a
testing room prior to their fMRI session. They were told to take as
much time as necessary to learn it. Once they felt comfortable, they
were asked to repeat it from memory simultaneously with click sounds
at 0.5 and 2 Hz. Before scanning, subjects were required to perform
the complex sequence, error-free, eight times from memory.
There were six types of block of 20s each (simple-slow, simple-fast,
complex-slow and complex-fast sequences; rest-slow and rest-fast
listening to metronome clicks but without movement). The different
types of block were presented in a pseudo-randomized order. At the
beginning of each block, instructions appeared with numbers counting
down from 3 to 0 over 3 s to help subjects predict onset and prepare
for each task. The set up was such that subjects performed the tasks
without sight of their hands.
MRI scanning
Scanning was performed on a 1.5T MRI system (Sonata; Siemens,
Erlangen, Germany). Scanning parameters included: TR 3600 ms; TE
50 ms; FOV 192 mm; distance factor (the edge-to-edge gap as a func-
tion of slice width) 50%; flip angle 90. We used 40 slices of 3 mm to
cover the whole cerebrum. Total scanning time for the fMRI task was
around 15 min per subject. A T1-weighted MDEFT sequence was
acquired to exclude structural abnormalities (Deichmann et al., 2004).
Statistical analysis of behavioural data
We primarily focused on sequence errors, which were detected by two
criteria. Single omitted or wrongly added button presses were counted
as one mistake. In sections with more complex errors only sequences
of three or more buttons in the appropriate order were counted as
correct. We also explored timing inaccuracy and its standard deviation
(SD) as additional measures of performance. This criterion was defined
by the time between a button press and closest click. Since auditory
cues were regular, this measure reflects the ability to anticipate the
next click rather than reaction time. A positive sign signified a button
was pressed after a click and vice versa. The Mann–Whitney test was
employed to compare performance between groups, separately for
each condition. Spearman’s correlation coefficient was used to test
for a correlation between the estimated years to clinical onset and
the SD of timing inaccuracy, for comparison with previous work
(Hinton et al., 2007).
Image data analysis
Pre-processing and statistical analysis of the fMRI data were carried
out using SPM5 software (www.fil.ion.ucl.ac.uk/spm/). Before
smoothing with an 8 mm full-width at half-maximum Gaussian
kernel, volumes were realigned and spatially normalized to a standard
echo-planar-imaging template in MNI space. A first-level analysis
based on the general linear model (Friston et al., 1995) was performed
for each subject individually. Task-related changes in fMRI signal were
estimated at each voxel by modelling each block separately for each of
the six conditions after convolving with a haemodynamic response
function. The instruction screen between blocks was modelled as
a separate regressor. Blocks during which subjects performed the
wrong condition (e.g. the simple instead of the complex condition)
were excluded by modelling them as separate regressors. Those
blocks were also excluded from performance analysis as these errors
do not represent problems with learning or sequence execution.
Button presses during the rest condition and errors on simple or com-
plex sequences were modelled as single events. Six regressors obtained
at the realignment step were included to account for head movements
(translations in three planes and rotations along three axes). The
resulting set of voxel values for each contrast constituted a statistical
parametric map, which then entered second level analysis. For group
inferences, we performed a random-effects analysis treating subjects
as a random variable. To characterize effects of increased speed or
complexity in controls or pre-symptomatic gene carriers we used
one-sample t-tests, entering the respective parametric images from
the first level analysis.
To test for differences with gene status we used a three-way fac-
torial design with two within-subject factors (COMPLEXITY: simple
and complex; SPEED: 0.5 and 2 Hz) and GROUP (pre-symptomatic
gene carriers and controls) as a between-subject factor. Age was
included as a covariate. Since we were interested in the cortical
motor system, we defined spheres of 1 cm radius as regions of
interests (ROIs) defined by activations described previously in healthy
controls for regions shown to be involved in this task (Lehericy et al.,
2006). These spheres were centered on peak activations in left M1,
pre-SMA, caudal SMA, dorsal premotor cortex (PMd) and superior
parietal lobe (SPL), found from activations of the control group.
Refer Table 2 for coordinates of these voxels. Although regional
Table 2 Imaging results from control group
Side x y z T P
Fast4 slow
Caudal SMA L 6 10 54 5.14 50.001
Primary motor cortex L 40 18 60 8.70 50.001
Dorsal premotor cortex L 18 8 54 6.45 50.001
Dorsal premotor cortex R 24 10 60 9.90 50.001
Superior parietal cortex L 24 58 56 9.74 50.001
Superior parietal cortex R 26 58 60 10.5 50.001
Complex4 simple
Pre-SMA 0 6 54 5.74 50.001
Dorsal premotor cortex L 24 0 54 7.11 50.001
Dorsal premotor cortex R 26 6 52 6.64 50.001
Superior parietal cortex L 22 68 58 6.39 50.001
Superior parietal cortex R 22 66 60 7.36 50.001
Areas showing greater activations are reported with uncorrected P-values and
co-ordinates in MNI space. Also, see Fig. 1. Reported voxels were used to define
regions of interest.
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activations due to SPEED and COMPLEXITY in a given anatomical
region may be localized very close to each other (Table 2), two sep-
arate ROIs were created. Choosing one over another could otherwise
have biased the sensitivity of detecting differences in the neuronal
processing of speed and complexity between groups. Correction for
multiple comparisons within each ROI was done using a family-wise
error correction as implemented in SPM5 with a critical P-value of 0.05
at the voxel level. P-values for regions outside these pre-determined
ROIs are reported within and corrected for a mask generated from the
main effect of the task (i.e. combination of the two movement con-
ditions at slow and fast speed conditions versus rest) at an uncorrected
threshold of P50.05 (see supplementary material for resulting mask).
This mask was preferred over a correction across the whole brain to
improve sensitivity outside predefined ROIs. Labelling of premotor
regions was done using maps of anatomical probabilities available
from version 1.5 of the anatomy toolbox (Eickhoff et al., 2005).
Correlational analysis
We tested for correlations between the estimated years to clinical
onset and cerebral activations with COMPLEXITY; SPEED and the
main effect of task in pre-symptomatic gene carrier. Based on previous
work (Bartenstein et al., 1997) we expected increasing activations with
approaching clinical onset in parietal areas and the reverse in premotor
regions. We included age as a regressor of no interest to partial out
non-specific age effects. The same ROIs and statistical thresholds were
applied as outlined above.
Results
Behaviour
Training took around 10–20 min and resulted in low error rates for
all four tasks (Table 3). Blocks in which subjects performed the
wrong condition were excluded from behavioural and imaging
data analysis. This was equally frequent for both groups and
affected 3.5% of all blocks, often at the first occurrence of a
new condition. No significant performance difference between
groups was found for any of the tasks (Table 3). No correlations
between error rate and estimated years to onset were found.
The SD of timing inaccuracy increased with approaching clinical
onset when pre-symptomatic gene carriers performed simple-slow
(r=0.72; P= 0.002), simple-fast (r=0.63; P= 0.01) and
complex-fast (r=0.58; P= 0.024) tasks, while this effect only
reached trend significance for the simple-slow condition
(r=0.50; P= 0.06). Scatter plots and correlations with the
imaging data are provided in a supplementary section.
Imaging results
Task related BOLD signal changes in the control group were very
similar to those reported (Lehericy et al., 2006). Increased pace of
sequential movements resulted in greater activations in M1, caudal
PMd, caudal SMA and superior parietal lobe. Pre-SMA, rostral
PMd as well as SPL displayed an increase in activation with
complexity (Fig. 1 top row and Table 2). A similar pattern of
task related activations were present in the pre-symptomatic
gene carrier group (Fig. 1, bottom row).
Primary and premotor areas
Across all movement conditions (main effect of GROUP),
pre-symptomatic gene carriers showed greater activation in
caudal SMA (at x, y, z=10, 4, 48; F= 16.03, Z= 3.67,
P= 0.012) (Fig. 2), uncorrelated with estimated years to onset.
In accordance with its executive role in motor control, task-related
activation of this region was modulated by the rate of sequential
movements but not by its complexity (bar plot in Fig. 2). A more
posterior region, still within the caudal SMA (at x, y, z= 2, 12,
48; T= 5.5; P= 0.05), showed increasing activations with increas-
ing SPEED as pre-symptomatic gene carriers approach clinical
onset (Fig. 3; left panel). While no interaction between the
effect of either complexity or rate was observed in the caudal
SMA, a rostral region located in the pre-SMA (x, y, z= 6, 6, 48)
showed a linear decrease in activation with increasing sequence
complexity when gene carriers were closer to estimated time
of clinical onset (T= 5.08; P= 0.031; Fig. 3; right panel). No
differences in the ROIs around M1 and PMd were found.
Table 3 Performance in each of the four motor conditions is given with median and range
Controls Pre-symptomatic Huntington’s disease Significance
Error complex, slow (%) 2 (0:6) 4 (0:11) 0.072
Error complex, fast (%) 4 (0:16) 7 (0:26) 0.25
Error simple, slow (%) 2 (0:10) 2 (0:8) 0.56
Error simple, fast (%) 0.5 (0:3) 2 (0:9) 0.082
Cue-response interval complex, slow (ms) 64 (36:363) 69 (188:261) 0.31
Cue-response interval complex, fast (ms) 16 (54:74) 2 (66:20) 0.46
Cue-response interval simple, slow (ms) 161 (38:337) 108 (57:286) 0.35
Cue-response interval simple, fast (ms) 22 (59:79) 16 (71:13) 0.75
SD cue-response interval complex, slow (ms) 238 (158:480) 257 (127:512) 0.76
SD cue-response interval complex, fast (ms) 67 (60:190) 89 (46:136) 0.17
SD cue-response interval simple, slow (ms) 195 (124:552) 249 (132:556) 0.58
SD cue-response interval simple, fast (ms) 64 (54:131) 70 (41:127) 0.55
Whitney test is used to compare groups.
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Superior parietal cortex
In the left SPL, the increase in task-related activation with
sequence complexity was attenuated in pre-symptomatic gene
carriers compared with controls, resulting in a significant interac-
tion between complexity and group (x, y, z=24, –64, 58;
F= 13.6, Z= 3.37, P= 0.031; Fig. 4; top row). A post hoc test
revealed that this effect does not correlate with the estimated
years to clinical onset.
In the right SPL, healthy controls showed a selective activation
only with the most difficult task, which required fast and complex
Figure 1 Pattern of activations for the main effect of SPEED
and COMPLEXITY for controls (top row) and pre-symptomatic
gene carriers (bottom row) are overlaid on the averaged
T1-images from all subjects (P50.001; uncorrected; Voxel
extent = 100).
Figure 2 Areas displaying differential activations with
group membership. The plot below depicts condition specific
activations compared with rest for indicated voxels in arbitrary
units (a.u.). Error bars represent one SEM activations are
displayed at P50.01; uncorrected (Voxel extent = 50).
Figure 3 Linear changes in activity in the caudal SMA and pre-SMA with the estimated years to diagnostic onset of Huntington’s
disease. Scatter plots illustrate peak correlations between estimated years to diagnostic onset and neuronal activations after controlling
for linear age-effects. The fitted regression line is shown with 95% mean prediction interval.
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movements. In contrast, the gene carrier group displayed activity
in right SPL with all movement conditions (bar plots in Fig. 4;
bottom row). These between-group differences in the activity
profile were reflected in a three-way interaction between SPEED,
COMPLEXITY and GROUP (x, y, z= 32, 62, 60; F= 13.24,
P= 0.036; Fig. 4, bottom row). No correlation of this interaction
with estimated years to clinical onset was found.
Supplementary table S1 summarizes all imaging results.
Discussion
We employed a sequential finger movement task that was
designed to probe executive (speed) and cognitive (sequence
complexity) aspects of manual motor control to tap into the pre-
clinical motor reorganization in Huntington’s disease. We
identified distinct regions in the mesial premotor cortex and
superior parietal cortex showing enhanced task related activity in
gene carriers compared with controls, including the caudal SMA as
well as the right and left SPL. Critically, the activity profile in these
regions differed from each other in the amount of extra recruit-
ment during the various task conditions. Compared with healthy
controls, pre-symptomatic gene carriers showed greater activations
of left caudal SMA with all movement conditions. The left SPL
showed a shift in the weighing of neuronal activity, with a relative
increase in activation during simple finger sequences but a rela-
tive reduction during complex sequences. In contrast, the
right SPL showed greater activations with all but the most
demanding movements. Our results show that the motor system
in Huntington disease recruits premotor and parietal areas in a
highly flexible manner depending on which motor functions
are demanded for task execution.
We discuss the results in four sections. In the first section, we
focus on the behavioural results; in the second part, we describe
regional changes in task related activation in the pre-symptomatic
gene carrier group. The third section compares the present results
to changes in motor activation associated with other genetic
mutations that can cause parkinsonism or dystonia. We end
the discussion with some methodological considerations.
Task performance
It is important to stress that the changes in task related neuronal
activity with group status were present in the absence of
behavioural differences. This also confirms previous work show-
ing that routine motor behaviour remains largely unaffected
in pre-symptomatic gene carriers (Giordani et al., 1995;
Campodonico et al., 1996). As performance was matched
between gene carrierss and controls, differential activation
between them reflects a primary effect of disease and/or of resul-
tant compensation. The variability of timing error increased with
approaching clinical onset, mirroring previous work (Hinton et al.,
2007). As shown in the supplementary material, no significant
correlation between this variability and neuronal activations was
found in the gene carrier group.
Figure 4 Regions in the right and left SPL displaying differential activations with indicated interactions. Activations are displayed at an
uncorrected P-value of p50.01 (Voxel extent = 50). Plots on the left depict condition specific activations compared with rest as in
Fig. 2.
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Regional changes in movement related
neuronal activity
Primary- and premotor areas
The caudal ‘executive’ part of the SMA showed increased
movement related activity in pre-symptomatic gene carriers
regardless of the pace or complexity of motor sequences. This is
consistent with a recent neuroimaging study in manifesting
Huntington’s disease patients (Gavazzi et al., 2007), but at
variance with the general notion that movement related activity
shifts from premotor to parietal areas in Huntington’s disease
(Bartenstein et al., 1997).
In the light of preserved task performance, we propose that this
greater activation effectively compensated for the effect of
Huntington’s disease-associated neurodegeneration in primary
motor areas. This interpretation is supported in two ways. First,
caudal SMA is functionally and anatomically well connected to
M1 (Picard and Strick, 2001; Johansen-Berg et al., 2004).
Second, a repetitive transcranial magnetic stimulation (rTMS)
study on healthy subjects has identified the caudal SMA as a
region that potentially compensates for disruption of M1 function
(Lee et al., 2003). In that study, rTMS was used to generate
a temporary lesion in left M1 in healthy subjects. Such focal
perturbation of M1 function resulted in an increase in coupling
between caudal SMA and M1 activity. The location of caudal
SMA closely matches that found in our study [at x, y, z=10,
4, 48] compared to x, y, z=12, 4, 56 (Lee et al., 2003).
When performing a similar analysis of functional coupling in a post
hoc analysis of our data, stronger positive coupling between
caudal SMA and ipsilateral M1 was found in pre-symptomatic
gene carriers compared with controls (see supplementary data).
Previous functional imaging studies show impaired activation of
M1 (Bartenstein et al., 1997; Gavazzi et al., 2007). This abnormal
activation of M1 is difficult to interpret as task performance in
these studies was either not matched between groups or not
recorded during imaging. We find normal activation of M1,
but a structural MRI study has previously revealed reduced M1
cortical thickness suggesting regional atrophy is present in the
pre-symptomatic stage (Rosas et al., 2005). Our subjects were
on average 6 years younger than those in the study by Rosas
and colleagues but had the same number of CAG repeats. In
addition, it is possible that the greater coherence between M1
and SMA may be responsible for a normal level of movement
related M1 activity in the pre-symptomatic gene carrier group.
The caudal SMA showed a gradual increase in activation with
faster movements as gene carriers approached clinical onset.
This correlation suggests that in the asymptomatic stage of
Huntington’s disease the compensatory role of caudal SMA may
increase with progressive neurodegeneration.
The pre-SMA represents a more cognitive motor area than the
caudal SMA (Picard and Strick, 2001). In agreement with previous
neuroimaging studies (Boecker et al., 1999; Lehericy et al., 2006),
we found increased activation of the pre-SMA with the complex
motor sequence relative to the simpler one. Correlational analyses
of fMRI data revealed a monotonic attenuation of the effect
of COMPLEXITY on task related activity in pre-SMA with
approaching clinical onset (Fig. 3). The attenuated neuronal activ-
ity in the pre-SMA in the context of complex movements
most likely indicates a progressive dysfunction of the pre-SMA
during the preclinical stage of Huntington’s disease. This assump-
tion is supported by a neuroimaging study in clinically affected
Huntington’s disease-patients that reported lesser activations in
pre-SMA with complex sequential movements (Bartenstein et al.,
1997).
Superior parietal lobule
Within the parietal lobule, mutation carriers also showed differen-
tial activations compared with controls. Plots of task specific
activations for the left SPL (Fig. 4) show a significant interaction
resulting from relatively higher activations in both simple tasks and
the reverse in complex movements, when pre-symptomatic gene
carriers are compared with controls. Of note, a different pattern
is observed in the right SPL and indicates compensatory
hyper-activation with the three simplest tasks. Ceiling effects
could explain equal recruitment between groups with the
fast-complex task.
There is also some evidence that the neurodegenerative process
may directly affect SPL. A prospective PET study found a reduction
of parietal resting state metabolism in gene carriers followed over
a 16 months period (Ciarmiello et al., 2006) while structural MRI
showed bilateral cortical thinning in BA7 (Rosas et al., 2005). It is
conceivable that increasing local damage limits the ability of SPL to
effectively compensate for motor dysfunction in more advanced
stages of symptomatic Huntington’s disease.
A differential role of the left and right parietal cortex in motor
control has been suggested (Rushworth et al., 2001). Figure 1
indicates that our task resulted in a relatively symmetrical activa-
tion of the parietal cortex even though the two hemispheres may
have distinct functional contributions. Our task was not designed
to disentangle side specific contributions of SPL to the motor
system (e.g. spatial attention versus motor attention) so that
a specific differential disease effect cannot be deduced from our
results. It is, however, noteworthy that morphometric MRI
reveales a leftward bias for Huntington’s disease-associated
degeneration (Muhlau et al., 2007; Klo¨ppel et al., 2008). This
could explain why activations with complex movements are
lesser in pre-symptomatic gene carriers than in controls on the
left, while they are of equal magnitude on the right.
In left SPL, gene carriers displayed greater activations with the
simple motor sequence, whereas controls showed equal or greater
activations of the same region with complex motor sequences
(bar plots in Fig. 4). This pattern suggests that the compensa-
tory mechanisms that are observed in gene carriers depend very
much on the demands of the task. A more differentiated picture of
preclinical compensation in Huntington’s disease has also emerged
from a recent study on working memory in pre-symptomatic gene
carriers (Wolf et al., 2007). Here again, compensatory mechanisms
varied with different levels of working memory load. While our
data disagrees with a simple shift of activations to parietal areas
suggested in previous work in clinically manifesting Huntington’s
disease patients, other results of our study are in accordance
with those reported by Bartenstein and colleagues (1997). In con-
cordance with their study, gene carriers tended to have greater
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SPL activations bilaterally with the simple sequence condition
compared with controls (Fig. 4). Yet, this increased activation
failed to reach significance in the pre-symptomatic stage under
study here.
Other basal ganglia disorders
A complex picture of motor compensation has also emerged from
related research in pre-symptomatic carriers of other basal ganglia
disorders (Ghilardi et al., 2003; Buhmann et al., 2005; Carbon
et al., 2008; van Nuenen et al., 2009). These studies have
shown partly overlapping patterns of hyper-activation that have
been interpreted in the context of functional compensation.
Familial, early-onset primary torsion dystonia is often caused by
an autosomal dominant genetic mutation in the DYT1 gene with
reduced penetrance of 25–30%. Asymptomatic DYT1-carriers
show deficient activations in dorso-lateral premotor cortex and
primary motor cortex which are associated with hyper-activation
in the cerebellum with sequence learning (Ghilardi et al., 2003;
Carbon et al., 2008). Non-manifesting subjects with a mutation in
the recessively inherited PARKIN gene have mild striatal dopami-
nergic dysfunction, often considered a model for pre-manifesting
Parkinson’s disease. Compensatory hyper-activation in these
asymptomatic carriers performing internally selected movements
was found in motor areas more rostral than those identified in
the present work. They include PMd and rostral cingulate cortex
(Buhmann et al., 2005; van Nuenen et al., 2009). These differ-
ences in regional patterns may be explained by the fact that the
tasks drew on different components of manual motor control. It is
also important to keep in mind that only the carriers of the
Huntington’s disease mutation will later develop the disease and
therefore show a truly pre-manifesting pattern of compensatory
changes. To improve our understanding of the range of com-
pensatory mechanisms, future work could directly compare
pre-symptomatic subjects of more than one basal ganglia disorder.
Methodological considerations
The activity patterns observed in healthy controls confirmed that
our experimental design probed executive and cognitive aspects of
motor control. There were increased activations in motor executive
areas with increasing pace of the motor sequence, while secondary
motor areas such as pre-SMA, rostral parts of PMd and SPL
showed greater activation with more complex movement patterns.
These results are in line with those reported previously (Lehericy
et al., 2006) and the known involvement of these areas in differ-
ent aspects of motor control (Picard and Strick, 2001; Rushworth
et al., 2001).
Our study has its focus on cortical regions but interactions with
well-known changes in the basal ganglia are very likely. Studies on
Huntington’s disease-specific metabolic patterns found with PET
imaging indicate a combination of cortical and subcortical regions
are involved (Feigin et al., 2007).
Our ROI based approach was designed to increase sensitivity for
detection of between-group differences in key cortical motor
areas. The pay-off is that our approach was less sensitive to
compensatory changes in brain regions where we did not have
a strong a priori hypothesis (Weeks et al., 1997).
Conclusion
In pre-symptomatic gene carriers, executive motor areas such as
the caudal SMA as well as cognitive motor areas such as the SPL
showed evidence for compensatory activation. We therefore
propose that the caudal SMA plays a central role in maintaining
executive aspects of motor control that increases with approaching
disease onset, compensating for dysfunctions in other executive
parts of the motor system (e.g. the M1). Likewise, the SPL
appears to be central to the compensation of regional dysfunctions
in other ‘cognitive’ motor regions (e.g. the pre-SMA).
The complex pattern of differences in neuronal processing found
in this study contradicts the claim that a shift of neuronal activity
from premotor to parietal regions constitutes the main feature of
compensation. Instead, our data are in keeping with regional com-
pensatory hyperactivation in an executive motor area (i.e. caudal
SMA). Depending on task difficulty, the SPL exhibits compensa-
tory functions. Studies on functional and anatomical connectivity
may prove useful for advancing our current understanding of the
interaction between these cortical regions and subcortical
structures.
Supplementary material
Supplementary material is available at Brain online.
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